Revolution Medicines, Inc. (RVMD) FY2024 YTD Q3 P&L / Income Statement
2024-01-01 to 2024-09-30
P&L / Income Statement
2024-01-01 to 2024-09-30
Swipe to see the full flow
Chart details
Revolution Medicines, Inc. (RVMD) FY2024 YTD Q3 P&L / Income Statement
Income statement for 2024-01-01 through 2024-09-30. Consolidated revenue, costs and expenses.
- Total revenue
- 0 US dollars
- Total operating expenses
- 473,214,000 US dollars
- Loss from operations
- negative 473,214,000 US dollars
- Total other income, net
- 67,690,000 US dollars
- Loss before income taxes
- negative 405,524,000 US dollars
- Benefit from income taxes
- 0 US dollars
- Net loss
- negative 405,524,000 US dollars
- Total operating expenses
- 473,214,000 US dollars
Chart connections
- Revenue minus operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG
Product waitlist
Health Check and Teardown for your own company
A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!